Modification of Superoxide Dismutase 1 (SOD1) Properties by a GFP Tag – Implications for Research into Amyotrophic Lateral Sclerosis (ALS)

• James C. Stevens ,

  Contributed equally to this work with: James C. Stevens, Ruth Chia

  Affiliation Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Ruth Chia ,

  Contributed equally to this work with: James C. Stevens, Ruth Chia

  Affiliation Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom

  ⨯
• William T. Hendriks,

  Affiliation Center for Regenerative Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Virginie Bros-Facer,

  Affiliation Sobell Department of Motor Science and Movement Disorders, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Jan van Minnen,

  Affiliation Department of Cell Biology and Anatomy, Hotchkiss Brain Institute, University of Calgary, Calgary, Canada

  ⨯
• Joanne E. Martin,

  Affiliation ICMS Pathology Group, Queen Mary University of London, London, United Kingdom

  ⨯
• Graham S. Jackson,

  Affiliation MRC Prion Unit, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Linda Greensmith,

  Affiliation Sobell Department of Motor Science and Movement Disorders, UCL Institute of Neurology, London, United Kingdom

  ⨯
• Giampietro Schiavo,

  Affiliation Molecular Neuropathobiology Laboratory, Cancer Research UK, London, United Kingdom

  ⨯
• Elizabeth M. C. Fisher

  * E-mail: e.fisher@prion.ucl.ac.uk

  Affiliation Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom

  ⨯